conference will also address the relationship between substances of abuse and HIV/AIDS, particularly with regard to etiology, genetics, epidemiology, prevention, treatment, health services, and therapeutic developments.
Each symposium will begin with a Symposium Lecture by a distinguished scientist who will provide an overview of the symposium topic and set the stage for the individual lectures that follow. Special emphasis will be placed in each symposium on the participation of young or junior investigators in addition to more established researchers. Each symposium will culminate with a brief summary by the symposium chairperson in order to frame the information presented in an appropriate context. An exciting and comprehensive program for the 18th Annual SNIP Conference has been assembled that brings together researchers from around the world to address basic cellular and biochemical processes related to substance abuse and HIV infection and AIDS, and to discuss the translational, clinical and epidemiological relevance of the latest scientific data on substance abuse and the HIV/AIDS pandemic.
A major goal of the Society is to promote the professional development of young investigators. The Society strongly supports the idea that young investigators are key to the continuation and expansion of the field of neuroimmune pharmacology. Thus, four events will be dedicated to young scientists, a practice that the Society has maintained over the years. In addition, the Asian American Pacific Islander (AAPI) workgroup of the NIDA Special Population Office has recognized the SNIP as one of the scientific forums to nurture the early careers of this special population of young investigators. Thus, they have collaborated with the Society to sponsor Early Career Investigator (ECI) awards that will provide distinguished young investigators the opportunity to present their research and to interact with their peers and with senior investigators.
The 18th SNIP Conference will open on Wednesday evening (April 25) with the Young Investigator Poster Session, which highlights recent research accomplishments by young researchers. The next event dedicated to young investigators is a special "Meet the Mentors" luncheon, to be held on Thursday afternoon (April 26). This luncheon will be attended by young investigators who are presenting their work at the Conference as well as by mentors from academia, industry, and the National Institutes of Health (NIH), who have influenced the field of neuroimmune pharmacology.
In addition to the Young Investigator Poster session, a General Poster Session will be held on Thursday, April 26. The third event will be the Young Investigators' Symposium, which will take place on Friday, April 27. The aim of this Symposium will be to highlight the work of three postdoctoral and three pre-doctoral researchers, selected by the Young Investigator Travel Award (YITA) Committee from the pool of over 74 abstracts submitted based on their quality and research accomplishments. The Bill Narayan Memorial Lecture, sponsored by Dr. Gendelman in memory of his mentor, the late Bill Narayan, DVM, Ph.D., will be the fourth event dedicated to young investigators. At this lecture, presented on Saturday, April 28, Tony Wyss-Coray, Ph.D. of Stanford University Medical Center will share his thoughts on the potential for young investigators to provide novel insights regarding the development of our scientific discipline and the essential role that reciprocity plays in the mentor-mentee relationship. This lecture will serve as a prime example of the important role that the mentor plays in the professional and intellectual growth of young investigators.
This year's conference will include two plenary lectures. On Thursday, April 26, Ming D. Li, Ph.D. will present the first Conference Plenary Lecture on the role of genetics and pharmacogenetics of addiction. Dr. Li's lecture will set the tone for the Conference in that it will highlight the integration of pharmacology and pharmacogenetics into the neuroimmunology of health and addictive diseases. The second plenary lecture will be presented by Jeffery Samet, M.D. at the opening session on Saturday, April 28. Dr. Samet will address the effects of alcohol and substance abuse on HIV/ AIDS prevention and treatment. His presentation will highlight the necessity of conducting research in neuroimmune pharmacology as it relates to the HIV/AIDS population and those at-risk for contracting the disease. There will be a total of seven symposia presented at the Conference. The theme of the first symposium will be, "HIV Latency and HIV Reservoirs in the Post-HAART Era", a topic that addresses an emerging health challenge in spite of the application of highly-active anti-retroviral therapy. This symposium will be sponsored by (JABSOM, University of Hawaii) will speak on neurological effects of marijuana in adolescents, cell-mediated gene therapy for neurAIDS, the role of increased cortisol levels in behavioral regulation of chronic marijuana users, the relationship between race, intracerebral hemorrhage, methamphetamine drug effects and untreated hypertension, and West Nile virus entry into the central nervous system, respectively.
The final symposium will focus on a new health risk in the United States: "spice" and bath salts. The 2012 SNIP Scientific Conference will be concluded on Saturday evening with a banquet and awards ceremony. At this banquet, Bryan Yamamoto, Ph.D. (University of Toledo School of Medicine) will share on a more personal and less scientific level his research journey on biogenic amines. Such a personal account of the experiences, triumphs, and tribulations involved in scientific research is meant to remind all participants that the purpose of medical research is for the betterment of society and humanity as a whole. This perspective, in particular, will serve to inspire young investigators to progress in their careers in medical research in a fashion that contributes to improving human health.
In summary, the 2012 SNIP Scientific Conference will highlight the current biomedical research indicating that substances of abuse play a role in the pathogenesis of HIV-1 infection and co-morbidity due to 'super-infection' and is reflected by the diversity of speakers. The program will emphasize the importance of defining the mechanisms by which substances of abuse modulate immune responses to compromise resistance to HIV infection. Translational and epidemiologic research presentations by both clinicians and basic researchers have been incorporated into the program in order to explore the correlation between laboratory findings and "realworld" experiences of street drug addicts.
The 18th Annual SNIP Scientific Conference will be held at the Hawaii Prince Hotel Waikiki, which offers 521 oceanfront rooms and 57 luxury suites along with a 27-hole golf course designed by Arnold Palmer and Ed Seay, signature restaurants offering Hawaii Regional and authentic Japanese cuisine, a fitness room, day spa and beauty salon, 13,000 sq. ft. of indoor function space, and 7,000 sq. ft. of outdoor function space. The hotel is located conveniently within walking distance of the Hawaii Convention Center, shopping areas, and beaches.
Again, welcome to the 18th Annual Conference of the Society on NeuroImmune Pharmacology.
